It’s not the end game I mentioned yesterday morning but rather the start of what will be the end game in my opinion. The announcement talks about significant collaboration and now we know cell therapy development takes a central position.
It’s good news for shareholders however we know that others will take their share as well. That change will not be good for those holders that believe the company will produce fountains of profits taking a short cut into their hungry bank accounts. The big fish that tramp the boards here will realise just how compromised they have become.
Alhambra.
PNV Price at posting:
$1.46 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)